BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 28245998)

  • 1. History and epidemiology of anabolic androgens in athletes and non-athletes.
    Kanayama G; Pope HG
    Mol Cell Endocrinol; 2018 Mar; 464():4-13. PubMed ID: 28245998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
    Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
    Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Illicit anabolic-androgenic steroid use.
    Kanayama G; Hudson JI; Pope HG
    Horm Behav; 2010 Jun; 58(1):111-21. PubMed ID: 19769977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do anabolic-androgenic steroids have performance-enhancing effects in female athletes?
    Huang G; Basaria S
    Mol Cell Endocrinol; 2018 Mar; 464():56-64. PubMed ID: 28711608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The history of the development of anabolic-androgenic steroids.
    Dotson JL; Brown RT
    Pediatr Clin North Am; 2007 Aug; 54(4):761-9, xi. PubMed ID: 17723875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short QT interval is unreliable marker of anabolic androgenic steroid abuse in competitive athletes.
    Djordjević V; Stanković I; Stipac AV; Putniković B; Nesković AN
    Srp Arh Celok Lek; 2012; 140(11-12):711-6. PubMed ID: 23350243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions.
    Nieschlag E; Vorona E
    Rev Endocr Metab Disord; 2015 Sep; 16(3):199-211. PubMed ID: 26373946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of anabolic androgenic steroid use by elite athletes and by members of the general public.
    Anawalt BD
    Mol Cell Endocrinol; 2018 Mar; 464():21-27. PubMed ID: 28943276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgenic--anabolic steroids and body dysmorphia in young men.
    Wroblewska AM
    J Psychosom Res; 1997 Mar; 42(3):225-34. PubMed ID: 9130179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents.
    Börjesson A; Lehtihet M; Andersson A; Dahl ML; Vicente V; Ericsson M; Ekström L
    Drug Test Anal; 2020 Apr; 12(4):514-523. PubMed ID: 31925932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training.
    Ip EJ; Barnett MJ; Tenerowicz MJ; Perry PJ
    Pharmacotherapy; 2011 Aug; 31(8):757-66. PubMed ID: 21923602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of androgenic-anabolic steroids in athletes.
    Hartgens F; Kuipers H
    Sports Med; 2004; 34(8):513-54. PubMed ID: 15248788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors for anabolic-androgenic steroid abuse among Jordanian collegiate students and athletes.
    Tahtamouni LH; Mustafa NH; Alfaouri AA; Hassan IM; Abdalla MY; Yasin SR
    Eur J Public Health; 2008 Dec; 18(6):661-5. PubMed ID: 18603598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective 30-year follow-up study of former Swedish-elite male athletes in power sports with a past anabolic androgenic steroids use: a focus on mental health.
    Lindqvist AS; Moberg T; Eriksson BO; Ehrnborg C; Rosén T; Fahlke C
    Br J Sports Med; 2013 Oct; 47(15):965-9. PubMed ID: 23613517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ruptured Tendons in Anabolic-Androgenic Steroid Users: A Cross-Sectional Cohort Study.
    Kanayama G; DeLuca J; Meehan WP; Hudson JI; Isaacs S; Baggish A; Weiner R; Micheli L; Pope HG
    Am J Sports Med; 2015 Nov; 43(11):2638-44. PubMed ID: 26362436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and Management of Anabolic Androgenic Steroid Use.
    Anawalt BD
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2490-2500. PubMed ID: 30753550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem.
    Melnik B; Jansen T; Grabbe S
    J Dtsch Dermatol Ges; 2007 Feb; 5(2):110-7. PubMed ID: 17274777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review.
    Piacentino D; Kotzalidis GD; Del Casale A; Aromatario MR; Pomara C; Girardi P; Sani G
    Curr Neuropharmacol; 2015 Jan; 13(1):101-21. PubMed ID: 26074746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications.
    Kanayama G; Brower KJ; Wood RI; Hudson JI; Pope HG
    Drug Alcohol Depend; 2010 Jun; 109(1-3):6-13. PubMed ID: 20188494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological and physical impact of anabolic-androgenic steroid dependence.
    Ip EJ; Lu DH; Barnett MJ; Tenerowicz MJ; Vo JC; Perry PJ
    Pharmacotherapy; 2012 Oct; 32(10):910-9. PubMed ID: 23033230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.